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R. KATZENSTEIN
Tolerance to histamine has been demonstrated with the guinea-
pig and some evidence is available indicating that it is also acquired
by the dog. This has been corroborated for the latter species, and
such animals with acquired tolerance have been studied to ascertain
possible associated structural and, more especially, functional expres-
sions of the change. These have included reactions to high altitude
and alterations in the ketosteroid content of the urine. Acknowl-
edgment is gratefully made to Dr. L. F. Nims of the Department
of Physiology for aid in the high altitude experiments and to Dr.
Konrad Dobriner of the Memorial Hospital, New York City, for
the ketosteroid determinations.
For the purposes of this presentation it is only necessary to
review briefly the studies available on tolerance to histamine acquired
by the guinea-pig and the dog, the so-called tachyphylaxis as distinct
from what is more commonly regarded as tolerance, and on the mor-
phological changes encountered after histamine death. E. S.
Karady' and Horton and his associates4 have shown that the lethal
dose of 0.05 mg. for every 100 gms. of guinea-pig can be increased
six-fold bystartingwith fractions of the lethal amount and increasing
this slowly in subsequent treatments. Wells and his associates"0
studied the secretion of hydrochloric acid after histamine in prepared
pouches of dogs' stomachs. The acid was progressively reduced
with repeated injections of the same quantity of histamine, from 128
at the start to 98 and 90.3 mg. per hour after two and six months,
respectively. These authors were of the opinion that this was due
toloss ofchlorides through the gastric pouch rather than to tolerance
to histamine. S. Karady,6 on the other hand, concluded that the
progressive decrease in the fall of the blood pressure with daily
injections of the same quantity of histamine in dogs was a manifes-
tation of tolerance. This type of functional reaction is sharply dif-
ferentiated from tachyphylaxis, an adaptation to a second injection
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of histamine shortly after an animal has recovered from a much
smaller dose, as observed by S. Karady6 and by Eichler and Killian.2
The latter were able to treat rabbits with as much as 150 mg. of
histamine without fatal outcome if this was done within 30 minutes
after a preliminary small injection.
The anatomical changes of the brain encountered with histamine
death, when an animal has survived long enough (24 hours) for
these to have developed, vary from necrobiosis of ganglion cells
of cerebrum and cerebellum to cerebral infarcts without vascular
occlusion.' These are considered to be dependent upon the degree
and the duration of the ischemia. The peptic ulcer of stomach and
duodenum, another manifestation of lack of tolerance, is ascribed to
hypersecretion of hydrochloric acid.3 8, That local ischemia par-
ticipates in its genesis has also been considered. Other lesions
described include hemorrhages in the adrenal cortex and marked
passive congestion of the viscera, particularly of the liver.
Experimental
Acquired tolerance of the dog to histamine is readily demon-
strable. Symptoms may be avoided even for a 50-mg. single injec-
tion, except for salivation, lacrimation, occasional vomiting, urination,
or defecation, when an initial dose of 1 mg. for a dog of 104 kg. has
been slowly increased on successive injections over a protracted
period. Only minor anatomical changes, including degeneration of
individual cerebral and cerebellar cortical ganglion cells, were
demonstrable in seven of eight dogs subjected to this procedure.
Four of these had only the mildest symptoms of the type outlined
above and no degenerated cortical ganglion cells. Three others had
minimal cell changes. Only one dog, No. 817, had a chronic gastric
ulcer. It was 3 cm. in diameter and was situated on the lesser
curvature of the prepylorus. Round, with a slightly elevated mar-
gin, it showed histologically extensive scarring at base and edges.
This animal deserves comment. On several occasions the amount
injected caused marked symptoms so that the dosage had to be
decreased. It should be said that the augmentation of the dose with
successive injections had been greater than usual. These facts
became evident: first, the increase in the amount of histamine toler-
ated with successive doses is limited, and second, when symptoms of
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the more severe type occur in the course of developing tolerance
anatomical lesions are likely to result.
The second group contrasts sharply with dogs that have acquired
tolerance to histamine. It is composed of 13 animals that received
single or repeated doses of histamine in sufficient amount to cause
marked and protracted symptomatology. Individual variation
accounts for differences both in this and in the pathological findings,
as is evidenced by animals 632 and 767. Even a single injection of
a very large amount of histamine may be followed by coma and by
extensive lesions of the central nervous system,7 the heart and the
alimentary canal. Changes in the heart muscle seem to be the most
constant, with those of the stomach and duodenum a close second,
followed by those of the central nervous system and of the spleen.
All of this is illustrated in Table 1.
TABLE 1
Dog No. of Histamine injections G.-I.
No. injections Initial Final Total Heart tract Spleen Brain
mg. mg. mg.
767 1 50 50 H+ N+ 0 N-H-
779 1 35 35 0 N+ 0 0
789 1 Low K 3 (Nembutal 3 N+ N+H 0 0
diet anesthesia)
801 1 75 75 0 0 0 0
777 2LowK 50 60 110 0 0 0 0
diet
808 2 50 60 110 N-HI-I H+N++ 0 0
845 2 70 100 170 H-- H-HI1 0 0
Nl-I-I N-H-
811 6 10 100 400 N-H 0 0 0
H+
809 7 40 80 440 H+ 0 N&H- N-H-
N-H
666 7 40 80 340 H+ 0 0 N+
632 8 20 70 540 N- H+-lI N+ N-H
636 44 20 100 1840 0 0 0 0
631 48 0.6 140 2430.6 0 0 0 0
H =hemorrhage; N =necrosis.
The pathological anatomical changes, with the exception of those
of the brain recently described,7 require special mention. The heart
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grossly is mottled by yellow patches seen from the epicardial and
more frequently fromtheendocardial surfaces. They are alsovisible
on tangential section of the myocardium. With the microscope
and special staining, focal accumulations of fat in the musde fibers
together with their necrosis and a peripheral gathering of mononu-
clear cells are readily demonstrable. The early lesions of stomach,
duodenum, and large bowel include edema, congestion, and hem-
orrhage of the mucosa and submucosa. These are followed by focal
necroses that appear as punched-out oval defects of the mucosa with
gray bases. Histologically, the necrosis of the mucosa may extend
into the submucosa. Its periphery may show an extensive poly-
morphonuclear reaction.
The lesions of the spleen are not related to the size or to the
congestion of the organ. Focal hyaline necroses of the Malpighian
corpuscles are most frequent. Both anemicand hemorrhagic infarcts
were found in oneanimal.
Tachyphylaxis, or a very similar effect, has been observed in
animals under study for histamine reaction while a blood pressure
record was being secured, as a guide, with the kymograph. The
repetition of a 4 mg. per kilo injection of histamine after 2 minutes,
when the blood pressure indicated marked hypotension, was toler-
ated with no change ofsymnptoms and the animals recovered, usually
within an hour or two. In other words, 8 mg. per kg. were given
in two doses several minutes apart with the survival of the animal,
when a single injection of 6 mg. per kg. would have been fatal in
10 minutes.
In the dogthe adrenal cortexdoes not hypertrophy with repeated
injections of histamine as it does in the rat. One animal only
showed nodular hyperplasia of the cortex; this probably was not
related to the experimental procedure as it failed to develop in the
other seven. Norwas it possible to demonstrate characteristic modi-
fication of the steroid pattern of the adrenal cortex in the dog after
prolonged histamine treatment.
These negative structural changes agreed with the functional
reactions for which the animals were tested. The latter induded
the effects of exposure to high altitude and the determination of the
17K steroid-content of the urine both before and after such exposure.
High Altitude. Two groups of animals were subjected to high
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altitude. This was applied rapidly as is indicated
table:
TABLE 2
in the following
Time in minutes
0
2
4
6
8
10
12
14
16
18
20
22
24
26
28
30
32
34
36
38
40
42
44
46
Atmospheric pressure
in mm. of Hg
760
650
540
450
380
330
290
260
230
210
200
190
180
175
170
165
160
155
150
145
140
135
130
125
Equivalent altitude
levels in feet
Sea level
4,000
9,000
14,000
18,000
21,000
24,000
27,000
30,000
32,000
33,000
34,000
35,000
35,000
36,000
36,000
37,000
38,000
38,000
39,000
40,000
40,000
41,000
41,000
The animals included both normal controls and histamine-toler-
ant dogs, six in each group. Simultaneous exposure of one of each
of these two groups in the same chamber was possible in about half
of the experiments. Otherwise a control and a tolerant dog were
successively exposed on the same day. The criteria of the reaction
of the animal to the high ceiling are expressed by Doctor Nims as
follows: The rate of respiration increases proportionately to the
decrease in atmospheric pressure. It reaches its maximum at about
36,000 feet, with values ranging from 90 to 140 a minute. Then
it decreases in linear progression until the "respiratory ceiling" is
attained. This occurs when the original respiration rate is approached
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in the vicinity of 20/min. Animals whose respiration falls below
this figure cannot be revived.
No significant difference was demonstrated in the "respiratory
ceiling" of tolerant and control animals. This is indicated in the
table that follows:
TABLE 3
Date Tolerant dog Respiratory ceiling Control Respiratory ceiling
min. min.
3/24 646 37.0 P1 30.0
3/24 817 39.0 P2 38.0
3/27 870 38.5 958 33.0
3/27 888 38.0 ... ......
4/9 888 40.0 958 44.0
4/9 870 45.5 ...... ......
4/10 967 42.0 988 44.5
4/10 968 41.0 (Died) ...... ......
4/21 870 44.0 (Died) P3 43.0
Average: Tolerant animals, 40.4 min. Control animals, 38.8 min.
Urinary 17 Ketosteroid. The content of this steroid in the urine
was determined for six dogs. Two of these were not given hista-
mine. Three of the other four had urinary 17 ketosteroid determi-
nations before histamine administration and after they had become
tolerant to as much as a 50 mg. daily injection; the fourth was only
tested when it had become tolerant.
The normal excretion of 17 ketosteroid in the two controls and
in the three dogs before histamine varied from 2.3 to 8.5 mg. in a
24-hour period. When tolerance to histamine had developed, it
ranged from 1.8 to 7.1 mg. during the same period. The variation
was not significant.
Sumnary
Tolerance to histamine can be developed by the daily, repeated,
intravenous injection of carefully graded increasing quantities of the
drug.
Such tolerant animals have only mild and transitory reactions to
amounts of histamine that would be followed by severe prostration
and even by death in the unprepared dog.
The growing tolerance to increasing quantities of histamine is
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indicated not only by the absence of symptoms but also by the almost
complete lack of those anatomical changes so marked in the non-
tolerant control. They include lesions ofthe central nervous system,
myocardium, gastro-intestinal tract, and spleen, and are ascribed to
the acute hypotension and consequent marked inefficiency of the
circulating blood volume.
Increased tolerance to histamine for the dog is not associated with
adrenal cortical hypertrophy, with greater urinary content of 17
ketosteroid, or with adaptation to low atmospheric oxygen content.
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